BIM
CELG

BRC Investment Management’s Celgene Corp CELG Stock Holding History

BRC Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,480
Closed -$299K – 189
2014
Q2 		$299K Hold
3,480
– – 0.04% 123
2014
Q1 		$243K Hold
3,480
– – 0.04% 133
2013
Q4 		$294K Sell
3,480
-34,014
-91% -$2.69M 0.05% 122
2013
Q3 		$2.89M Sell
37,494
-6,040
-14% -$423K 0.44% 50
2013
Q2 		$2.55M Buy
+43,534
New +$2.62M 0.46% 40

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BRC Investment Management's CELG Position: Q3 2014 in Review

BRC Investment Management sold out of Celgene Corp (CELG) in Q3 2014, closing a stake of 3,480 shares — an estimated $299K sold.

BRC Investment Management first reported a position in CELG in Q2 2013 and held it in 5 quarters. The position peaked at $2.89M in Q3 2013. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

  • BRC Investment Management reported no remaining Celgene Corp position as of Q3 2014 after selling out during the quarter.
  • BRC Investment Management sold 3,480 Celgene Corp shares in Q3 2014, an estimated $299K.
  • BRC Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 5 quarters.
  • BRC Investment Management's Celgene Corp position peaked at $2.89M in Q3 2013.
  • 1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on BRC Investment Management's 13F filing for Q3 2014, filed 21 Oct 2014.